The Italy Human Identification Market was valued at $14.24 Million in 2026 and projected to reach to $21.57 Million by 2031, representing a compound annual growth rate of 8.7%. Italy's human identification market is positioned for sustained growth as healthcare providers prioritize digital transformation and patient data security.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Italy's human identification market is valued at $14.24 million in 2026 and is projected to reach $21.57 million by 2031, demonstrating robust expansion within Southern Europe's healthcare sector.
With an 8.7% CAGR from 2026-2031, Italy's market growth outpaces many European counterparts, driven by modernization of healthcare infrastructure and regulatory compliance requirements.
Italian healthcare institutions are increasingly implementing biometric identification systems for patient management, staff authentication, and secure access control across hospitals and clinics.
Government initiatives and digital health mandates are accelerating the adoption of human identification technologies across Italy's public and private healthcare networks.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | RAPID DNA ANALYSIS KITS & REAGENTS (Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 10.9% from 2026 to 2031 |
| Largest Segment | FORENSICS (Application) |
| Market Size Base Year (Billions) | ~USD 1.01 (2026) |
| Revenue Forecast (Billions) | ~USD 1.69 (2031) |
| Segments Covered | Product, Type, Technology, Application, End User |
5 segment dimensions are covered across the global market.
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| FORENSIC LABORATORIES | 11.56 | 13.03 | 14.52 | 15.99 | 17.46 | 18.9 | 20.27 | 21.75 | 8.4 |
| OTHER END USERS | 2.8 | 3.15 | 3.5 | 3.84 | 4.18 | 4.51 | 4.82 | 5.16 | 8.1 |
| RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES | 4.31 | 4.83 | 5.35 | 5.86 | 6.36 | 6.83 | 7.28 | 7.77 | 7.7 |
| TOTAL | 18.67 | 21.02 | 23.37 | 25.7 | 28 | 30.24 | 32.37 | 34.68 | 8.2 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ALERE INC | United States | Private Company | Infectious disease diagnostics,Cardiometabolic and point-of-care analyzers,Toxicology and workplace drug testing, |
| PERKIN ELMER INC | United States | Public Company | Diagnostics instruments and automation platforms,Diagnostics reagents, assays, and test kits,Life-science reagents and genomic workflow tools, |
| TECAN GROUP LTD. | Switzerland | Public Company | Liquid handling and automation platforms,Microplate readers, washers, and detection,Consumables, reagents, immunoassays, and antibodies, |
| BECKMAN COULTER | United States | Private Company | Clinical diagnostics and core lab systems,Life science research and discovery tools,Industrial and particle characterization systems, |
| NATERA INC | United States | Public Company | Reproductive Health (Panorama, Horizon, Vistara, Fetal Focus, Anora),Oncology MRD & Genomic Profiling (Signatera, Latitude, Altera, Empower),Transplant & Renal (Prospera, Renasight), |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| QIAGEN N.V. | Netherlands | Public Company | Sample technology consumables and instruments,Molecular diagnostics assays (immune response, oncology, sexual and reproductive health),Research PCR, enzymes, and PCR instruments (qPCR, digital PCR), |
| ANDE CORPORATION | United States | Public Company | Grain and Oilseed Merchandising,Plant Nutrients and Fertilizers,Ethanol Production and Trading, |
| HAMILTON COMPANY | United States | Public Investment Firm | Primary and secondary fund-of-funds,Direct credit,Direct/co-investments and buyouts, |
| AUTOGEN INC. | Australia | Private Company | Motor Insurance,Home and Contents Insurance,Pet Insurance, |
| OXFORD NANOPORE TECHNOLOGIES PLC | United Kingdom | Public Company | PromethION (P2, P24, P48),GridION / GridION Q,MinION Mk 1D and other portable devices, |
| BODE CELLMARK FORENSICS, INC. | United States | Private Company | Forensic DNA casework and missing person identification services,CODIS and private DNA databanking services,Software (BodeLIMS, Bode Match, Bode Collection Point, Qualtrax), |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Life Science segment,Clinical Diagnostics segment,Other / Software and Services, |
| ZEISS | Germany | Public Company | Ophthalmology – Diagnostics (slit lamps, OCT, fundus, perimetry),Ophthalmology – Surgical (microscopes, phaco, vitrectomy, IOLs, laser vision correction),Microsurgery – Visualization and Tumor Workflow, |
Alere Inc is a United States-based private company founded in 1981 with 9,700 employees. The company operates in the diagnostics and healthcare industry.
PerkinElmer Inc is a United States-based public company founded in 1937 with 11,000 employees. The company provides diagnostics, life sciences, and analytical solutions.
Tecan Group Ltd is a Switzerland-based public company founded in 1980 with 3,166 employees. The company specializes in laboratory automation and diagnostics solutions.
Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees. The company provides diagnostics and laboratory equipment solutions.
Natera Inc is a United States-based public company founded in 2003 with 6,138 employees. The company specializes in genetic testing and diagnostics.
Thermo Fisher Scientific Inc is a United States-based public company founded in 1956 with 125,000 employees. The company is a global leader in life sciences, diagnostics, and laboratory solutions.
QIAGEN N.V. is a Netherlands-based public company founded in 1984 with 5,500 employees. The company provides molecular diagnostics and life sciences solutions.
ANDE Corporation is a United States-based public company founded in 1947 with 2,028 employees. The company operates in the diagnostics and life sciences sector.
Hamilton Company is a United States-based private investment firm founded in 1991 with 785 employees. The company operates in the investment and financial services sector.
Autogen Inc is an Australia-based private company founded in 2004 with 50 employees. The company operates in the diagnostics and life sciences sector.
Oxford Nanopore Technologies PLC is a United Kingdom-based public company founded in 2005 with 1,316 employees. The company develops nanopore sequencing technology for genomic analysis.
Bode Cellmark Forensics, Inc is a United States-based private company founded in 1995 with 85 employees. The company provides forensic DNA analysis and services.
Bio-Rad Laboratories, Inc is a United States-based public company founded in 1952 with 7,450 employees. The company provides diagnostics and life sciences research products.
Zeiss is a Germany-based public company founded in 1846 with 5,798 employees. The company provides optical and imaging solutions for diagnostics and research.
Italy's human identification market is valued at $14.24 million in 2026 and is projected to reach $21.57 million by 2031.
Italy's human identification market is growing at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2031.
Italy's market growth is driven by digital healthcare modernization, EU regulatory compliance requirements, and increased adoption of biometric technologies in healthcare institutions.
Italy represents a significant segment within Europe's human identification market, with steady growth supported by strong healthcare infrastructure and regulatory frameworks aligned with EU standards.
Italy's human identification market is forecasted to reach $21.57 million by 2031, representing a $7.33 million increase from the 2026 baseline of $14.24 million.
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global human identification market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of leading market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the global human identification market. The secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), World Bank, INTERPOL, Scientific Working Group on DNA Analysis Methods (SWGDAM), Combined DNA Index System (CODIS), National DNA Data Bank of Canada, US Census Bureau, Federal Bureau of Investigation (FBI, US), American Society of Crime Laboratory Directors, American Academy of Forensic Sciences, National Center for Forensic Science (US), Forensic Science Regulator (UK), Australian Criminal Intelligence Commission (Australia), Medicines & Healthcare Products Regulatory Agency (UK), Statistics Canada, Ministry of Attorney General (UK), Federal Criminal Police Office (BKA, Germany), Pharmaceuticals and Medical Devices Agency (Japan), and National Crime Records Bureau (NCRB, India); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, professional associations. These sources were also used to obtain key information on major players, market classification, and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Following an initial assessment of the global human identification market landscape through secondary research, comprehensive primary research was undertaken. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from pharmaceutical and biotechnology firms, CROs, CMOs, and academic and research institutions. Additionally, interviews were conducted with key supply-side participants, including C-suite and senior executives, product managers, and marketing and sales leaders from prominent manufacturers, distributors, and channel partners. The research covered six major geographical regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while 30% were conducted with demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to comprehensively understand market dynamics.
The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure
Both bottom-up and top-down approaches were used to estimate and validate the total size of the global human identification market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Human identification is the process of establishing and confirming an individual's unique identity. This process involves various techniques and methods that help determine individuality and link unknown materials or evidence to known identities. Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology, among other applications, with DNA analysis and profiling a key tool in this sector. It also builds citizen databases to ensure better healthcare and develops an organized set of records.
With the given market data, MarketsandMarkets offers customizations to meet your company’s needs. The following customization options are available for this report:
Portfolio Assessment
Full forecast, segment splits, and company analysis for all Human Identification Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report